About this trial
Prospective non-randomized intervention case control study on patients with a BMI \> 35. The intervention group/cases (n=600) is comprised of bariatric patients who undergo bariatric surgery and the control group (n=600) of age, weight and comorbidity matched patients who choose not to undergo bariatric surgery. The overall aim is to examine prevalence of the spectrum of fatty liver disease (NAFLD) in these patients and the prognostic significance of NAFLD.
Eligibility criteria
Qualifiers
Age > 18 years
BMI >35 kg/m2 and referred for bariatric surgery at Hospital of South West Jutland, Denmark
Able to give written informed consent.
Age > 18 years
Disqualifiers
Active viral hepatitis
Not willing or able to consent
Contraindications to liver biopsy
Trial design
Treatments tested in this trial
- Bariatric surgery
Treatment groups
Sponsors and collaborators
Esbjerg Hospital - University Hospital of Southern Denmark
Lead sponsor
University of Southern Denmark
Sponsor institution
University of Southern Denmark
Collaborator
Odense University Hospital
Collaborator
Esbjerg University Hospital of South-West Jutland
Collaborator